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ABSTRACT 
Objective: The objective of the present work was to develop and validate a novel, specific, precise and reliable method for estimation of 
gemcitabine hydrochloride in bulk and polymeric nanoparticles using UV-visible spectroscopy method. 
Methods: The UV-Visible spectrophotometric determination was performed with double beam Systronics UV-visible spectrophotometer; model 
UV-2201 (India). The proposed methods were validated for various parameters like linearity, precision, accuracy, robustness, ruggedness, 
detection, quantification limits, and formulation analysis as per international conference on harmonization (ICH) guidelines. 
Results: The method was based on measurement of absorbance at wavelength maxima i.e. 267.2 nm, λmax of the drug in distilled water, phosphate 
buffer pH 6.8 and 7.4. The method obeyed Beer Lambert’s law in the concentration range of 5-30 µg/ml andR2-value was found to be 0.999. 
Moreover, the % drug recovered from polymeric nanoparticles was found to be 97.97%. 
Conclusion: According to results, the currently developed method shows compliance with acceptance criteria with Q2 (R1) and international conference on 
harmonization (2005) guidelines, because the % RSD was found to be less than 2%. The developed method was simple, accurate and précised. 
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Method validation is the process which is used to confirm that the 
analytical procedure employed fora specific test is suitable for its 
intended use. Results from method validation can be used to judge 
the quality, reliability and consistency of analytical results as well as 
it is an integral part of any good analytical practice [1]. 
Gem HCl is 2'-Deoxy-2',2'-difluoro cytidines hydrochloride 
(C9H11F2N3O4. HCl) as shown in fig. 1, deoxycytidine analogue with 
small molecular weight (299.66), has a short half-life (17 min), 
appearance (white to off white solid) and quickly decomposed to 
inactive products after administration [2]. The drug is highly hydrophilic 
in nature, slightly soluble in methanol and practically insoluble in 
ethanol and polar organic solvents. The major limitation for the use of 
gem HCl is represented by its rapid metabolic inactivation (deamination 
operated by deoxycytidine deaminase) responsible for its short half-life 
with its low but still important systemic toxicity [3].  
 
 
Fig. 1: Structure of gem HCl 
 
Moreover, the gem HCl is used as an antiviral agent, an enzyme 
inhibitor, an immunosuppressive agent, radiation-sensitizing agents 
and also has been successfully used in other tumors such as ovarian 
cancer, mesothelioma and head and neck cancers in combinations 
with other cytotoxic drugs [4-5]. 
By the extensive literature survey, we found that there are numerous 
methods, such as high-performance liquid chromatography (HPLC) [6-
8], UV-spectrophotometric [9], liquid chromatography with mass 
detector (LC-MS) [10-11], UPLC-MS/MS [12], have been used to 
measure the gem HCl in formulations and biological samples. 
However, these methods are involved with sophistication, skills, 
extraction, and more expensive than proposed method. 
The reported chromatographic methods were not cost effective due to 
the use of highly sophisticated detectors and costly solvents. Thus, the 
present investigation was aimed to develop a rapid, simple, selective, 
sensitive, precise, accurate, robust, reproducible, and economic and 
stability indicating spectrophotometric method in bulk as well as in 
nanoparticles. Moreover, the development of the analytical method is 
required for analysis of drug in the delivery system as well as for 
evaluation of in vitro release pattern of the drug from the developed 
delivery system. The presently developed method was validated as per 
international conference on harmonization guidelines. The aim of the 
present study was to develop and validate a new simple, sensitive, 
rapid, reliable and precise spectrophotometric method for the analysis 
of gem HCl in the bulk as well as in polymeric nanoparticles and to 
check the percent drug recovery from a novel delivery system of drug 
i.e. nanoparticles. 
MATERIALS AND METHODS 
Chemicals and reagents 
Gemcitabine hydrochloride supplied as a gift sample by Neon 
laboratories, Mumbai. Sodium chloride, potassium dihydrogen 
orthophosphate, disodium hydrogen phosphate from CDH laboratories. 
All chemicals and reagents used in the study were of analytical grade.  
Instrumentation 
A double beam systronics UV-visible spectrophotometer, model UV-
2201 (India) with a spectral bandwidth of 1 nm, wavelength 
accuracy of±0.5 nm and a pair of 1 cm quartz cells were used to 
measure the absorbance of the resulting solutions. 
Preparation of solvent system for analysis study 
For the spectroscopic analysis of drug, three solvents were selected. 
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Phosphate buffer (pH 7.4): Dissolve 2.38 g of disodium hydrogen 
phosphate, 0.19 g of potassium dihydrogen phosphate and 8.0 g of 
sodium chloride in sufficient water and make up the volume to 
produce 1000 ml. Adjust the pH if necessary. 
Phosphate buffer (pH-6.8): Place 125 ml of 0.2 M potassium 
dihydrogen phosphate in a volumetric flask, add the 56 ml of 0.2 M 
sodium hydroxide and then add water to make up the volume. 
Preparation of 0.2 M potassium dihydrogen orthophosphate 
solution: 27.218 g of potassium dihydrogen phosphate was 
dissolved in water and make up the volume up to 1000 ml. 
Preparation of 0.2 M sodium hydroxide: 8 g of NaOH was dissolved 
in water and diluted with water up to 1000 ml [13].  
Preparation of standard stock solution and working solution 
The 10 mg of gem HCl has weighed accurately and transferred into 10 ml 
volumetric flask and dissolved. Then, the solution was diluted up to the 
mark with an appropriate solvent (phosphate buffer pH-7.4, pH 6.8 and 
distilled water). The clear solution was obtained having the strength of 
1000 µg/ml (standard stock solution). From this stock solution, 10 ml 
was taken into a 100 ml volumetric flask, diluted up to 100 ml to get the 
solution of 100 µg/ml concentration and filtered through Whatman filter 
paper before analyzing (working solution) [14]. 
Procedure for calibration curve 
The standard solutions were prepared by the proper dilution of the 
primary stock solution with phosphate buffer pH 7.4, pH 6.8 and 
distilled water to obtain working standard. All the measurements 
were performed at room temperature. The stock solutions scanned 
in the UV range 200-800 nm by using an appropriate blank. For 
linearity study, dilutions were made for the drug in the range of 1-40 
µg/ml concentrations were prepared by diluting the stock solution 
with all the three working solvents.  
Assay of gem HCl polymeric nanoparticles 
The proposed method was successfully applied for the 
determination gem HCl in polymeric nanoparticles. An accurately 
measured volume of polymeric nanoparticles equivalent to 10 mg (7 
ml) of the drug was transferred into 10 ml volumetric flask and 
volume were made up to the mark with distilled water, filtered 
through whatmann filter paper. The suitable volume of solution was 
further diluted with water to obtain concentration 10µg/ml. Then, 
the aliquot was scanned in the UV range (200-400 nm). The amount 
of drug present in the polymeric nanoparticles was calculated [15]. 
Validation of methods  
Linearity The aliquots of concentration ranging 1-40 µg/ml were 
analyzed in triplicate. The results obtained were used to calculate 
the equation of the line by using linear regression by the least-
squares regression method [16]. 
Accuracy The accuracy of the method is the closeness of the 
measured value to the true value for the sample. For recovery study, 
the solutions were prepared at levels 75%, 100% and 125% of test 
solutionand taken absorbance of each solution in triplicate [17]. 
Precision The intra-day and inter-day precisions of the proposed 
spectrophotometric methods were determined by estimating the 
corresponding response thrice on the same day and on three 
different days, over a period of one week and the results were 
reported in terms of relative standard deviation [18]. 
Repeatability The repeatability was determined by analyzing six 
samples of same concentrations of drug (20µg/ml). From the 
resulting absorbance, the standard deviation and relative standard 
deviation were calculated [19]. 
Limit of detection (LOD) and limit of quantification (LOQ) 
It is the lowest concentration of analyte in a sample that can be detected 
but not necessary quantified. The LOD and LOQ were determined by 
using standard deviation of the response and slope approach as defined 
in International Conference on Harmonization (ICH) guidelines. LOD and 
LOQ values were calculated using the relation, 
LOD = 3.3 ∗  σ/s 
The lowest concentration or amount of analyte that can be 
determined quantitatively with an acceptable level of repeatability 
precision and trueness 
LOQ = 10 ∗  σ/s 
Where σ is the standard deviation (n=3) of reagent blank 
determination and s is the slope of the calibration curve [20-21]. 
Robustness and ruggedness 
The robustness of the proposed method was tested by changing 
parameters such as wavelength range and slit width. Ruggedness 
was determined by different analysts, using similar operational and 
environmental conditionsand the results were reported in terms of 
% RSD [22]. 
RESULTS AND DISCUSSION 
Determination of absorption maxima (λ max)  
The standard stock solution of gem HCl having the concentration 
1000µg/ml was further diluted to 100µg/ml with distilled water, pH 
7.4 and 6.8. The absorbance of resulting solution was scanned in the 
UV spectrophotometer ranging from 200-400 nm. The λmax was 
found to be 267.2 nm as shown in fig. 2. The higher values of 
correlation coefficient (R2) indicate good linearity of calibration 
curve for drug in bulk as well as in formulation. 
 
 
Fig. 2: Absorption spectrum of gem HCl showing maximum absorbance at 267.2 nm 
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The linearity studies of the drug were performed by plotting 
different concentrations of standard solution against their 
respective absorbance as shown in fig. 3. The drug was found to be 
linear in the concentration range of 5-30µg/ml.  
The correlation co-efficient values were found to be 0.999, and the 
calibration curve shows that the drug obeys beer’s law limit within 
the concentration range. Furthermore, the overlay spectra of gem 
HCl in working solutions support the linearity results observed in 
the standard curve as in fig. 4. 
 
Table 1: Comparison of absorbance of gem HCl in different solvent 
Concentration(µg\ml) PBS pH 7.4*±SD PBS pH 6.8*±SD Distilled water*±SD 
5 0.170±0.003 0.185±0.004 0.191±0.0033 
10 0.310±0.004 0.342±0.003 0.356±0.002 
15 0.465±0.002 0.476±0.004 0.493±0.001 
20 0.618±0.004 0.638±0.001 0.640±0.004 
25 0.760±0.003 0.774±0.002 0.777±0.002 
30 0.944±0.002 0.946±0.004 0.941±0.001 
 *Each value is the average of three determinations (n=3) 
 
 
Fig. 3: Calibration plot of gemcitabine HCl 
 
 
Fig. 4: Overlay spectra of drug in phosphate buffer 7.4, 6.8and distilled water 
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Precision (Intraday and Interday Study) 
The Precision was determined as:  
Intraday precision 
The intraday precision was determined by analyzing the drug at 
particular concentration for three times on the same day taking 
the time intervals of 3 h at 10:00 AM, 1:00 PM and 4:00 PM 
respectively. 
Interday precision 
The Inter day precision was determined by analyzing the samples 
daily, for three consecutive days. The values of relative standard 
deviation (%RSD) were in the range of 0.089-0.651 % respectively. 
This indicates the reproducibility of the method. The results are 
shown in table 2. The precision results indicate that the current 
method was reliable and repeatable [23]. Thus, the methodology can 
be applied for the determination of drug in different formulations 
like targeting of pancreatic as well as for bladder cancer. 
 



















pH 7.4 0.60 0.61 98±0.005 97±0.003 0.406 0.522 
pH 6.8 0.63  0.62 99.9±0.004 98.4±0.005 0.181 0.651 
Distilled 
Water 
0.64 0.634 98.3±0.001 99.3±0.002 0.180 0.089 
*is the mean of three values (n=3) 
 
Accuracy 
To ensure the accuracy, recovery studies were performed by 
standard addition method at 75%, 100% and 125% levels of drug 
concentration, to the pre-analyzed samples and percent recovery 
values were calculated. Recovery experiment indicated the absence 
of interferences from the commonly encountered pharmaceutical 
additives and excipients and values of mean recovery were in the 
range of 99.32-100.33 %. The results for the recovery studies were 
found in the desired limits as shown in table 3. 
 
Table 3: Results of recovery studies at three levels and statistical analysis 
Solvent Accuracy (% recovery)* 
75% (10+5 µg/ml)±SD 100% (10+10 µg/ml)±SD 125% (10+15 µg/ml)±SD 
pH 7.4 99.32±0.09 100.33±0.48 100.69±0.81 
pH 6.8 99.66±0.1 100.66±0.32 100.69±0.76 
Distilled Water 99.77±0.12 100.11±0.23 100.33±0.98 
*Each value is the average of three determinations (n=3) 
 
Repeatability 
The repeatability of the instrument was validated by taking the 
absorbance of six samples of the same concentration (20µg/ml) in 
different working solvents.  
The SD and %R. SD were in the given limits as shown in table 4. The 
repeatability of methodology is very important for routine result 
analysis of drug in bulk as well as in formulations. Moreover, the 
current results proved that there was no significant change in 
results on repetition of methodology [24]. 
  
Table 4: Results of repeatability studies in different working solvents 
Concentration(µg\ml) Absorbance(pH 7.4)* Absorbance(pH 6.8)* Absorbance (distilled water)* 
20 0.616 0.639 0.638 
20 0.618 0.638 0.638 
20 0.617 0.638 0.638 
20 0.618 0.637 0.631 
20 0.618 0.637 0.638 
20 0.619 0.634 0.638 
Mean 0.617±0.0013 0.637±0.00172 0.636±0.00285 
SD 0.00103 0.00172 0.00285 
%RSD 0.16 0.27 0.44 
*is the mean of three values (n=3) 
 
Robustness study 
Robustness studies assumed that the small variations in any of the 
variables did not significantly affect the results (table 5). The 
robustness study provided the liability of the proposed method 
during routine analysis and proved that change in instrument, show 
no significant effect on results. 
Ruggedness study 
Ruggedness of the method was determined by carrying out the 
analysis by different analyst and the respective absorbance of 
20μg/ml was noted. The result was indicated as %RSD, which 
should be less than 2 as shown in table 6. The ruggedness analysis, 
indicates that there was no significant change in reliability and 
repeatability of methodology with the change of analyst [23]. 
Assay of polymeric nanoparticles (PNP’s) 
The optimized spectrophotometric method was applied to the direct 
determination of gem HCl in polymeric nanoparticles without any 
sample extraction or filtration. From the absorbance value, the drug 
content was calculated. Furthermore, the results obtained from 
assay of polymeric nanoparticles showed that the current method 
was validated because drug content recovered was 97.97% with % 
RSD 0.44 as shown in table 7. 
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Table 5: Results of robustness studies and statistical analysis 
Concentration 
(µg\ml) 
Absorbance(pH 7.4)* Absorbance(pH 6.8)* Absorbance(distilled water)* 
665.9 669.2 665.9 669.2 665.9 669.2 
20 0.618 0.570 0.635 0.581 0.638 0.569 
20 0.618 0.571 0.631 0.581 0.631 0.568 
20 0.618 0.571 0.633 0.581 0.639 0.568 
20 0.619 0.571 0.634 0.581 0.638 0.568 
20 0.619 0.571 0.638 0.581 0.638 0.568 
20 0.617 0.571 0.638 0.580 0.638 0.568 
Mean 0.618 0.571 0.634 0.581 0.637 0.568 
SD 0.000735 0.00040 0.00278 0.000408 0.00296 0.0142 
%RSD 0.12 0.071 0.43 0.071 0.46 0.071 
*is the mean of three values (n=3) 
 
Table 6: Results of ruggedness studies (by two analysts) in different working solvents 
Concentration 
(µg\ml) 
Absorbance(pH 7.4)* Absorbance(pH 6.8)* Absorbance(distilled water)* 
Analyst I Analyst II Analyst I Analyst II Analyst I Analyst II 
20 0.619 0.617 0.637 0.636 0.63 0.632 
20 0.619 0.619 0.637 0.637 0.63 0.629 
20 0.618 0.618 0.637 0.635 0.63 0.633 
20 0.618 0.619 0.637 0.637 0.63 0.633 
20 0.618 0.618 0.636 0.636 0.635 0.633 
20 0.618 0.618 0.637 0.637 0.632 0.633 
Mean 0.618 0.618 0.637 0.636 0.631 0.632 
SD 0.00051 0.0011 0.013 0.0008 0.002 0.001 
%RSD 0.083 0.189 0.064 0.12 0.323 0.25 
*is the mean of three values (n=3) 
 
Table 7: Results of the assay of pharmaceutical formulation 
Formulation Amount taken*(µg/ml) UV spectrophotometric method 
Amount recovered (µg/ml)*±SD % Drug recovered*±SD % RSD* 
PNP’s  10 9.797±0.09 97.97±0.9 0.44 
*is the mean of three values (n=3). 
 
Table 8: Summary of all the validation parameters 
Validation parameter Phosphate buffer (pH 7.4) Phosphate buffer (pH 6.8) Distilled water 
Absorption maxima (λ max) 267.2 nm 267.2 nm 267.2 nm 
Linearity Range 5–30 µg/ml 5–30 µg/ml 5–30 µg/ml 
Standard Regression Equation y = 0.0307x+0.0074 y = 0.0301x+0.0346 y = 0.0295x+0.0304 
Intercept 0.0074 0.0346 0.0304 
Slope (m) 0.0307 0.0301 0.0295 
Correlation Co-efficient (R2) 0.998 0.999 0.999 
% RSD for Intra-day (n=3) Precision 0.406 0.181 0.180 
% RSD for Inter-day (n=3) Precision 0.522 0.651 0.089 
Repeatability (% RSD) 0.167 0.270 0.448 
LOD 0.268 0.532 0.197 
LOQ 0.815 1.61 0.679 
 
CONCLUSION 
A simple, accurate, precise, robust and rapid UV visible 
spectrophotometric method has been developed for estimation of 
gem HCl from its pharmaceutical formulation. Thus it can be 
extended for routine analysis of gem HCl in pharmaceutical 
industries and hospitals and research laboratories. Unlike the LC/MS 
procedure and HPLC procedures, the UV-visible spectrophotometer 
instrument is simple and not of highly expensive on the other hand 
in simplicity and user friendly the method could be considered 
superior in comparison with the previously reported methods. The 
current method has wide range of accuracy, precision, repeatability, 
robustness and ruggedness. 
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